High incidence of celiac disease in patients with systemic sclerosis

Journal of Rheumatology

Volumn 36, Issue 5, 2009, Pages 965-969

  Rosato, Edoardo ^a   De Nitto, Daniela ^a   Rossi, Carmelina ^a   Libanori, Valerio ^a   Donato, Giuseppe ^a   Di Tola, Marco ^a   Pisarri, Simonetta ^a   Salsano, Felice ^a   Picarelli, Antonio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Autoantibodies; Autoimmune diseases; Celiac disease; Scleroderma

Indexed keywords

ENDOMYSIUM ANTIBODY; GLUTEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; ANTIIDIOTYPIC ANTIBODY; AUTOANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CELIAC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DUODENUM MUCOSA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; AGED; BLOOD; COMORBIDITY; IMMUNOLOGY; ITALY; MIDDLE AGED; MUCOSA; PATHOLOGY; SMOOTH MUSCLE;

ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIBODIES; CELIAC DISEASE; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; MUCOUS MEMBRANE; MUSCLE, SMOOTH; SCLERODERMA, SYSTEMIC; TRANSGLUTAMINASES; YOUNG ADULT;

EID: 67449096008     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.081000     Document Type: Article

References (46)

1. LeRoy EC, Black C, Fleishmaier R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1998;15:202-5.
2. Johnson SR, Feldman BM, Hawker GA. Classification criteria for systemic sclerosis subsets. J Rheumatol 2007;34:1855-63.
3. Salsano F, Letizia C, Proietti M, et al. Significant changes of peripheral perfusion and plasma adrenomedullin levels in N-acetylcysteine long term treatment of patients with sclerodermic Raynauds phenomenon. Int J Immunopathol Pharmacol 2005;18:761-70.
4. Sjogren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 1994;37:1265-82.
5. Di Ciaula A, Covelli M, Berardino M, et al. Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma. BMC Gastroenterol 2008;8:1-7.
6. Valentini G, Black C. Systemic sclerosis. Best Pract Res Clin Rheumatol 2002;16:807-16.
7. Sjogren RW. Gastrointestinal features of scleroderma. Curr Opin Rheumatol 1996;8:569-75.
8. Farina G, Rosato E, Francia C, et al. High incidence of Helicobacter pylori infection in patients with systemic sclerosis: Association with sicca syndrome. Int J Immunopathol Pharmacol 2001;14:81-5.
9. Schuppan D. Current concepts of coeliac disease pathogenesis. Gastroenterology 2000;119:234-42.
10. Fasano A, Catassi C. Current approaches to diagnosis and treatment of coeliac disease: an evolving spectrum. Gastroenterology 2001;120:636-51.
11. Catassi C, Fabiani E, Iacono G, et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr 2007;85:160-6.
12. Abdulkarim AS, Murray JA. Review: The diagnosis of coeliac disease. Aliment Pharmacol Ther 2003;17:987-95.
13. Cianci R, Cammarota G, Lolli S, Gasbarrini GB, Pandolfi F. Abnormal synthesis of IgA in coeliac disease and related disorders. J Biol Regul Homeost Agents 2008;22:99-104.
14. Biagi F, Ellis HJ, Yiannakou JY, et al. Tissue transglutaminase antibodies in coeliac disease. Am J Gastroenterol 1999;94:2187-92.
15. Russo PA, Chartrand LJ, Seidman E. Comparative analysis of serologic screening tests for the initial diagnosis of coeliac disease. Pediatrics 1999;104:75-8.
16. Farrell RJ, Kelly CP. Coeliac sprue. N Engl J Med 2002;346:180-8.
17. Caramaschi P, Stanzial A, Volpe A, et al. Celiac disease in a rheumatology unit: a case study. Rheumatol Int 2008;28:547-51.
18. Larsson K, Carlsson A, Cederwall E, Jönsson B, Neiderud J, Jonsson B. Annual screening detects celiac disease in children with type 1 diabetes. Pediatr Diabetes 2008;9:354-9.
19. O'Leary C, Walsh CH, Wieneke P, et al. Celiac disease and autoimmune Addison's disease: a clinical pitfall. QJM 2002;95:79-82.
20. Luft LM, Barr SG, Martin LO, Chan EK, Fritzler MJ. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases. J Rheumatol 2003;30:2613-9.
21. Larizza D, Calcaterra V, De Giacomo C, et al. Celiac disease in children with autoimmune thyroid disease. J Pediatr 2001;139:738-40.
22. Evron E, Abarbanel JM, Branski D, Sthoeger ZM. Polymyositis, arthritis, and proteinuria in a patient with adult celiac disease. J Rheumatol 1996;23:782-3.
23. Villalta D, Girolami D, Bidoli E, et al. High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue transglutaminase antibodies. J Clin Lab Anal 2005;19:6-10.
24. De Bem RS, Da Ro Sa Utiyama SR, Nishihara RM, et al. Celiac disease prevalence in Brazilian dilated cardiomyopathy patients. Dig Dis Sci 2006;51:1016-9.
25. Cooper BT, Holmes GK, Cooke WT. Coeliac disease and immunological disorders. Br Med J 1978;1:537-9.
26. Zammit-Maempel I, Adamson AD, Halsey JP. Sclerodactyly complicating celiac disease. Br J Rheumatol 1986;25:396-8.
27. Sheehan NJ, Stanton-King K. Polyautoimmunity in a young woman. Br J Rheumatol 1993;32:254-6.
28. Marguerie C, Kaye S, Vyse T, Mackworth-Young C, Walport MJ, Black C. Malabsorption caused by coeliac disease in patients who have scleroderma. Br J Rheumatol 1995;34:858-61.
29. Sheehan NJ, Stanton-King K. Co-existent coeliac disease and scleroderma. Br J Rheumatol 1996;35:807.
30. Valentini G, Silman AJ, Veale D. Assessment of disease activity. Clin Exp Rheumatol 2003;21:39-41.
31. Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rehumatol 2003;21:42-6.
32. Sblattero D, Berti D, Trevisiol C, et al. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol 2000;95:1253-7.
33. Trevisiol C, Ventura A, Baldas V, et al. A reliable screening procedure for coeliac disease in clinical practice. Scand J Gastroenterol 2002;37:679-84.
34. Picarelli A, Sabbatella L, Di Tola M, et al. Anti-endomysial antibody of IgG1 isotype detection strongly increases the prevalence of celiac disease in patients affected by type I diabetes mellitus. Clin Exp Immunol 2005;142:111-5.
35. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185-94.
36. Picarelli A, Di Tola M, Sabbatella L, et al. Usefulness of the organ culture system in the in vitro diagnosis of coeliac disease: a multicentre study. Scand J Gastroenterol 2006;41:186-90.
37. Picarelli A, Sabbatella L, Di Tola M, et al. Forty-eight hours of biopsy culture improve the sensitivity of the in vitro gliadin challenge in the diagnosis of coeliac disease. Clin Chem 2001;47:1841-3.
38. Carroccio A, Iacono G, D'Amico D, et al. Production of anti-endomysial antibodies in cultured duodenal mucosa: usefulness in coeliac disease diagnosis. Scand J Gastroenterol 2002;37:32-8.
39. Di Tola M, Barillà F, Trappolini M, Palumbo HF, Gaudio C, Picarelli A. Anti-tissue transglutaminase antibodies in acute coronary syndrome: an alert signal of myocardial tissue lesion? J Intern Med 2008;263:43-51.
40. Di Tola M, Sabatella L, Anania MC, Viscido A, Caprilli R, Picarelli A. Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin Chem Lab Med 2004;42:1092-7.
41. Picarelli A, Di Tola M, Sabatella L, et al. Anti-tissue transglutaminase antibodies in arthritic patients: a disease-specific finding? Clin Chem 2003;49:2091-4.
42. Lock J, Gilmour JE, Unsworth DJ. Anti-tissue transglutaminase, anti-endomysium and anti-R1-reticulin autoantibodies, the antibody trinity of coeliac disease. Clin Exp Immunol 1999;116:258-62.
43. Uhlig HH, Lichtenfeld J, Osman AA, Richter T, Mothes T. Evidence for existence of celiac disease autoantigens apart from tissue transglutaminase. Eur J Gastroenterol Hepatol 2000;12:1017-20.
44. Fasano A. Systemic autoimmune disorders in celiac disease. Curr Opin Gastroenterol 2006;22:674-9.
45. Watts T, Berti I, Sapone A, et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci USA 2005;102:2916-21.
46. Ventura A, Magazzù G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 1999;117:297-303.